Literature DB >> 32662850

Use of Run-in Periods in Randomized Trials.

Xiqian Huo1,2, Jane Armitage2.   

Abstract

Mesh:

Year:  2020        PMID: 32662850     DOI: 10.1001/jama.2020.6463

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial.

Authors:  Mary M McDermott; Lydia Bazzano; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Kathryn Domanchuk; Lihui Zhao; Tamar S Polonsky; Dongxue Zhang; Donald Lloyd-Jones; Christiaan Leeuwenburgh; Jack M Guralnik; Melina R Kibbe; Kate Kosmac; Michael H Criqui; Lu Tian
Journal:  JAMA       Date:  2022-10-04       Impact factor: 157.335

Review 2.  New approaches to symptomatic treatments for Alzheimer's disease.

Authors:  Jeffrey Cummings
Journal:  Mol Neurodegener       Date:  2021-01-13       Impact factor: 14.195

3.  Designing Clinical Trials in Wilson's Disease.

Authors:  Peter Ott; Aurélia Poujois; Thomas Damgaard Sandahl; Karl Heinz Weiss; Peter Ferenci; Michael L Schilsky; Aftab Ala; Frederick K Askari; Anna Czlonkowska; Ralf-Dieter Hilgers; Eve A Roberts
Journal:  Hepatology       Date:  2021-10-05       Impact factor: 17.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.